Epigral Ltd reported record Q4FY26 revenue of ₹736 Crore, up 17% year-on-year, driven by volume growth and improved realizations. The Board proposed a final dividend of ₹5 per share. While PAT stood at ₹82 Crore, EBITDA margins improved to 23%. The company continues its strategic capex expansions in CPVC and Epichlorohydrin capacities.
